OneMedNet 2025 Q2 Earnings Strong Performance as Net Income Surges 183%

OneMedNet (ONMD) reported its fiscal 2025 Q2 earnings on August 13th, 2025. The results marked a significant turnaround from the previous year, with the company returning to profitability. Management provided no specific revenue or EPS guidance but emphasized continued focus on operational efficiency and market expansion.

The results exceeded expectations, with the company posting a net income of $2.98 million and an EPS of $0.07, reversing a $3.59 million net loss and a $0.14 loss per share in the same period in 2024. The performance signals a strong rebound after three years of sustained losses in the sector.

In the second quarter, OneMedNet reported total revenue of $155,000, a 31.7% decline from $227,000 in the prior-year period. The drop in revenue was attributed to a challenging market environment. Subscription revenue contributed $47,000, while web imaging revenue accounted for $108,000 of the total.

The company returned to profitability in the second quarter with a net income of $2.98 million and an EPS of $0.07, reversing a net loss of $3.59 million and a loss per share of $0.14 in the same period in 2024. This marked a 183.1% improvement in net income and a 150.0% positive change in EPS, reflecting a strong operational turnaround. Despite this positive outcome, the company has sustained losses for three consecutive years during this quarter, highlighting ongoing financial challenges.

Following the earnings report, the stock price of OneMedNet rose 5.56% during the latest trading day and increased by 1.59% during the most recent full trading week. However, the stock declined 12.96% month-to-date.

A strategy of buying OneMedNet shares after a revenue increase quarter-over-quarter and holding for 30 days has yielded no returns over the past three years. This approach generated a CAGR of 0.00%, an excess return of -46.32%, and underperformed the benchmark return of 46.32%. The strategy also exhibited a maximum drawdown of 0.00% and zero volatility, indicating a risk profile that failed to deliver any meaningful gains or diversification benefits.

CEO John Lin emphasized that OneMedNet continues to prioritize technological innovation and expansion in digital health solutions to drive sustainable growth. He acknowledged the competitive nature of the market but noted that the company is leveraging AI-driven diagnostic tools and partnerships with key healthcare providers to strengthen its market position. Lin expressed cautious optimism about the second half of 2025, citing increased client engagement and a growing project pipeline. He reiterated the company’s commitment to operational efficiency and long-term value creation, highlighting strategic investments in R&D and talent development to maintain leadership in the healthcare industry.

For the remainder of 2025, the company expects to maintain its current revenue trajectory, with a focus on expanding market share in key sectors, including telemedicine and AI-enabled diagnostics. Management highlighted plans to increase R&D investment to support innovation and enhance product offerings, though no specific quantitative revenue or EPS guidance was provided. The company remains committed to delivering strong profitability, as demonstrated by the $2.98 million net income and $155,000 in revenue for the second quarter.

In recent news, Bitcoin reached a record high of over $124,000 driven by favorable U.S. legislation and rising U.S. equities. Meanwhile, Nigeria’s telecom regulator called for public cooperation to protect infrastructure, warning of the economic and national security risks associated with disruptions. The Federal Government announced plans to temporarily close the border with Niger Republic for security reasons, particularly during the upcoming by-elections. Additionally, the National Emergency Management Agency issued a flood alert in Adamawa State, warning of rising water levels that have surpassed the 6.0-meter threshold.